Protheragen

Our company is a globally operating service provider and one of the world leaders in the development and delivery of advanced drug therapies for rare diseases. Over the years, we have worked to innovate the way modern drug discovery works, contributing to improving the health and well-being of many people around the world.

We not only provide global customers with a wide range of services for rare disease genomic analysis, gene therapy vector, and strategy design but also provide efficacy testing, safety, and toxicology analysis for therapeutic products. [More Information]